Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer – Eli Lilly

Written by | 14 Jun 2026

Eli Lilly and Company announced positive topline results from the Phase III LIBRETTO-432 clinical trial of Retevmo (selpercatinib) as adjuvant therapy versus placebo. The study met its primary… read more.

Delirium after surgery is a strong predictor of cognitive decline in older adults

Written by | 13 Jun 2026

Researchers found postoperative delirium was strongly associated with long-term cognitive decline and the effect was not explained by rehospitalizations, highlighting the long-term impact of delirium on brain health…. read more.

Canada faces surge in social anxiety

Written by | 13 Jun 2026

A new Canadian study has found that social anxiety disorder (SAD) now affects nearly 1 in 7 adults — a 71% increase since 2002 — making it one… read more.

World’s First Dual Glucose-Ketone Sensing Technology for People with Diabetes Secures CE Mark – Abbott

Written by | 13 Jun 2026

Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing technology for people with diabetes. Branded as Libre Duo and Libre Duo 10 Day,… read more.

A new era in canine arthritis care: VMD approves Zoetis’ Lenivia for long-acting OA pain relief

Written by | 12 Jun 2026

The UK’s Veterinary Medicines Directorate (VMD) has approved Lenivia® (izenivetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in dogs. Granted on 29 May 2026, the… read more.

New survey: One in five US adults unaware of link between diet and blood cholesterol levels

Written by | 12 Jun 2026

On the heels of updated cholesterol management guidance that recommends earlier screening and establishes target goals for LDL “bad” cholesterol based on an individual’s risk factors, a new Physicians Committee for Responsible… read more.

Roche Launches Certified Liver Disease Panel to Support Chronic Liver Disease Management in Europe – Roche

Written by | 12 Jun 2026

Roche announced the launch of its comprehensive Liver Disease Panel, a suite of certified algorithms designed to help clinicians better identify and manage chronic liver disease (CLD). By… read more.

Equine Influenza: A surge that cannot be ignored

Written by | 11 Jun 2026

With 95 confirmed or suspected outbreaks recorded in Britain by early June 2026 and horse shows turning away horseboxes at the gate, the equine flu crisis has moved… read more.

How do we tackle preferences regarding animal-derived medicines?

Written by | 11 Jun 2026

Clinical Pharmacy Congress highlights For patients with religious or ethical beliefs — including Muslims, Jews, Sikhs, Buddhists, and vegans — the animal origin of a medicine can directly… read more.

NICE (UK) positive for Winrevair (sotatercept) for treating pulmonary arterial hypertension – Merck Inc

Written by | 11 Jun 2026

NICE (UK): Sotatercept, with other pulmonary arterial hypertension (PAH) treatments, can be used as an option to treat PAH in adults with World Health Organization functional class (WHO… read more.

Research addresses barriers to success for antibody-based therapies for solid head, neck and pancreatic tumors

Written by | 10 Jun 2026

Eben Rosenthal, MD, the Barry and Amy Baker Professor and Chair of the Department of Otolaryngology-Head and Neck Surgery at Vanderbilt Health, is the senior author of the… read more.

It may not just be what’s in ultra-processed foods, but how they’re made

Written by | 10 Jun 2026

Concerns about the health effects of ultra-processed foods are growing, as studies increasingly link them to conditions such as heart disease, diabetes, and even early death. But scientists are still debating what’s driving… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.